A good move bringing someone on like Dr. Tom Duthy on to the board. His presentations are more technically focused and clearly explained than the broker podcasts. With only 4 weeks of board experience, he is also all over the story and details. The EV of the company is being compared against other drug companies at a similar phase in development. Many multiples of share price appreciation ahead and great buying opportunity at the moment in my opinion.
IXC Price at posting:
82.0¢ Sentiment: Buy Disclosure: Held
